Differential proteomic analysis of noncardia gastric cancer from individuals of Northern Brazil

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Leal, Mariana Ferreira ^a   Chung, Janete ^a   Calcagno, Danielle Queiroz ^a   Assumpção, Paulo Pimentel ^b   Demachki, Samia ^b   da Silva, Ismael Dale Cotrim Guerreiro ^a   Chammas, Roger ^c   Burbano, Rommel Rodríguez ^b   de Arruda Cardoso Smith, Marília ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; ENOLASE 1; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 1; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BOOTSTRAPPING; BRAZIL; CANCER PATIENT; CANCER PROGNOSIS; CELL PROTECTION; CELL STRESS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENERGY YIELD; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GLYCOLYSIS; HUMAN; HUMAN TISSUE; MALE; NONCARDIA GASTRIC CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; STOMACH CANCER; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CLUSTER ANALYSIS; DNA-BINDING PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84864459027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042255     Document Type: Article

References (74)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Whelan SL, Parkin DM, Masuyer E (1993) Trends in cancer incidence and mortality. Lyon: IARC Scientific Publications.
3. INCA (2009) Estimate/2010- Incidence of Cancer in Brazil. Rio de Janeiro: Instituto Nacional de Câncer/Ministério da Saúde. 98.
4. Resende ALS, Mattos IE, Koifman S, (2006) Mortalidade por câncer gástrico no estado do Pará. Arquivos de Gastroenterologia 43: 6.
5. El-Serag HB, Mason AC, Petersen N, Key CR, (2002) Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50: 368-372.
6. Powell J, McConkey CC, (1992) The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1: 265-269.
7. Crew KD, Neugut AI, (2006) Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362.
8. Kamangar F, Dores GM, Anderson WF, (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150.
9. Panani AD, (2008) Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett 266: 99-115.
10. Werner M, Becker KF, Keller G, Hofler H, (2001) Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 127: 207-216.
11. Berth M, Moser FM, Kolbe M, Bernhardt J, (2007) The state of the art in the analysis of two-dimensional gel electrophoresis images. Appl Microbiol Biotechnol 76: 1223-1243.
12. Siu KW, DeSouza LV, Scorilas A, Romaschin AD, Honey RJ, et al. (2009) Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. J Proteome Res 8: 3797-3807.
13. Nam NH, Parang K, (2003) Current targets for anticancer drug discovery. Curr Drug Targets 4: 159-179.
14. Lin LL, Huang HC, Juan HF, (2012) Discovery of biomarkers for gastric cancer: A proteomics approach. J Proteomics.
15. Shah MA, Ajani JA, (2010) Gastric cancer-an enigmatic and heterogeneous disease. Jama 303: 1753-1754.
16. Lauren P, (1965) The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. an Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand 64: 31-49.
17. Batista dos Santos SE, Rodrigues JD, Ribeiro-dos-Santos AK, Zago MA, (1999) Differential contribution of indigenous men and women to the formation of an urban population in the Amazon region as revealed by mtDNA and Y-DNA. Am J Phys Anthropol 109: 175-180.
18. Sobin LH, Wittekind CH (2002) TNM: Classification of malignant tumours. New York: Wiley-Liss.
19. Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S, (1992) Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 30: 192-200.
20. Lobo Gatti L, Agostinho Jn F, De Labio R, Balbo Piason F, Carlos Da Silva L, et al. (2003) Helicobacter pylori and cagA and vacA gene status in children from Brazil with chronic gastritis. Clin Exp Med 3: 166-172.
21. Gorg A, Weiss W, Dunn MJ, (2004) Current two-dimensional electrophoresis technology for proteomics. Proteomics 4: 3665-3685.
22. Efron B, (1979) Bootstrap Methods: Another Look at the Jackknife. Annals of Statistics 7: 26.
23. Forrest MS, Lan Q, Hubbard AE, Zhang L, Vermeulen R, et al. (2005) Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect 113: 801-807.
24. Nishigaki R, Osaki M, Hiratsuka M, Toda T, Murakami K, et al. (2005) Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 5: 3205-3213.
25. Chen EI, Cociorva D, Norris JL, Yates JR 3rd, (2007) Optimization of mass spectrometry-compatible surfactants for shotgun proteomics. J Proteome Res 6: 2529-2538.
26. Huang da W, Sherman BT, Tan Q, Collins JR, Alvord WG, et al. (2007) The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8: R183.
27. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
28. Bai Z, Ye Y, Liang B, Xu F, Zhang H, et al. (2011) Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer. Int J Oncol 38: 375-383.
29. He QY, Cheung YH, Leung SY, Yuen ST, Chu KM, et al. (2004) Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4: 3276-3287.
30. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW, (2004) The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 14: 491-499.
31. Ebert MP, Rocken C, (2006) Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol 18: 847-853.
32. Yoshihara T, Kadota Y, Yoshimura Y, Tatano Y, Takeuchi N, et al. (2006) Proteomic alteration in gastic adenocarcinomas from Japanese patients. Mol Cancer 5: 75.
33. Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, et al. (2003) The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 18: 505-509.
34. Li N, Zhang J, Liang Y, Shao J, Peng F, et al. (2007) A controversial tumor marker: is SM22 a proper biomarker for gastric cancer cells? J Proteome Res 6: 3304-3312.
35. Zhang J, Kang B, Tan X, Bai Z, Liang Y, et al. (2007) Comparative analysis of the protein profiles from primary gastric tumors and their adjacent regions: MAWBP could be a new protein candidate involved in gastric cancer. J Proteome Res 6: 4423-4432.
36. Cai Z, Zhao JS, Li JJ, Peng DN, Wang XY, et al. (2010) A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics 9: 2617-2628.
37. Wu C, Luo Z, Chen X, Wu C, Yao D, et al. (2009) Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Oncol Rep 21: 1429-1437.
38. Wang KJ, Wang RT, Zhang JZ, (2004) Identification of tumor markers using two-dimensional electrophoresis in gastric carcinoma. World J Gastroenterol 10: 2179-2183.
39. Cheng Y, Zhang J, Li Y, Wang Y, Gong J, (2007) Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. BMC Cancer 7: 191.
40. Meuwissen TH, Goddard ME, (2004) Bootstrapping of gene-expression data improves and controls the false discovery rate of differentially expressed genes. Genet Sel Evol 36: 191-205.
41. Westfall PH, Young SS(1993) Resampling-based multiple testing: Examples and methods for p-value adjustment. New York: John Wiley & Sons.
42. Lim BH, Cho BI, Kim YN, Kim JW, Park ST, et al. (2006) Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med 38: 455-465.
43. Burbano RR, Assumpcao PP, Leal MF, Calcagno DQ, Guimaraes AC, et al. (2006) C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. Anticancer Res 26: 2909-2914.
44. Takeno SS, Leal MF, Lisboa LC, Lipay MV, Khayat AS, et al. (2009) Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization. Cancer Genet Cytogenet 190: 1-7.
45. Warburg O, (1956) On respiratory impairment in cancer cells. Science 124: 269-270.
46. Cairns RA, Harris IS, Mak TW, (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11: 85-95.
47. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
48. Gatenby RA, Gillies RJ, (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899.
49. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB, (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18: 54-61.
50. Vousden KH, Ryan KM, (2009) p53 and metabolism. Nat Rev Cancer 9: 691-700.
51. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, et al. (2006) p53 regulates mitochondrial respiration. Science 312: 1650-1653.
52. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, et al. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120.
53. Khayat AS, Guimaraes AC, Calcagno DQ, Seabra AD, Lima EM, et al. (2009) Interrelationship between TP53 gene deletion, protein expression and chromosome 17 aneusomy in gastric adenocarcinoma. BMC Gastroenterol 9: 55.
54. Cesar AC, Borim AA, Caetano A, Cury PM, Silva AE, (2004) Aneuploidies, deletion, and overexpression of TP53 gene in intestinal metaplasia of patients without gastric cancer. Cancer Genet Cytogenet 153: 127-132.
55. Fox JG, Wang TC, (2007) Inflammation, atrophy, and gastric cancer. J Clin Invest 117: 60-69.
56. Calcagno DQ, Guimaraes AC, Leal MF, Seabra AD, Khayat AS, et al. (2009) MYC insertions in diffuse-type gastric adenocarcinoma. Anticancer Res 29: 2479-2483.
57. Calcagno DQ, Leal MF, Assumpcao PP, Smith MA, Burbano RR, (2008) MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol 14: 5962-5968.
58. Calcagno DQ, Leal MF, Demachki S, Araujo MT, Freitas FW, et al. (2010) MYC in gastric carcinoma and intestinal metaplasia of young adults. Cancer Genet Cytogenet 202: 63-66.
59. Calcagno DQ, Leal MF, Seabra AD, Khayat AS, Chen ES, et al. (2006) Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol 12: 6207-6211.
60. Costa Raiol LC, Figueira Silva EC, Mendes da Fonseca D, Leal MF, Guimaraes AC, et al. (2008) Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma. Cancer Genet Cytogenet 181: 31-35.
61. Leal MF, Calcagno DQ, Demachki S, Assumpcao PP, Chammas R, et al. (2012) Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol 18: 1531-1537.
62. Pancholi V, (2001) Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 58: 902-920.
63. Capello M, Ferri-Borgogno S, Cappello P, Novelli F, (2011) alpha-enolase: a promising therapeutic and diagnostic tumor target. Febs J 278: 1064-1074.
64. Yan GR, Xu SH, Tan ZL, Yin XF, He QY, (2011) Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells. Proteomics 11: 3657-3664.
65. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E, (2007) Energy metabolism in tumor cells. Febs J 274: 1393-1418.
66. Giallongo A, Feo S, Moore R, Croce CM, Showe LC, (1986) Molecular cloning and nucleotide sequence of a full-length cDNA for human alpha enolase. Proc Natl Acad Sci U S A 83: 6741-6745.
67. Kostenko S, Moens U, (2009) Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 66: 3289-3307.
68. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C, (2007) Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol 81: 15-27.
69. Zoubeidi A, Gleave M, (2012) Small heat shock proteins in cancer therapy and prognosis. Int J Biochem Cell Biol.
70. Giaginis C, Daskalopoulou SS, Vgenopoulou S, Sfiniadakis I, Kouraklis G, et al. (2009) Heat Shock Protein-27,-60 and-90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol 9: 14.
71. Kapranos N, Kominea A, Konstantinopoulos PA, Savva S, Artelaris S, et al. (2002) Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance. J Cancer Res Clin Oncol 128: 426-432.
72. Takeno S, Noguchi T, Kikuchi R, Sato T, Uchida Y, et al. (2001) Analysis of the survival period in resectable stage IV gastric cancer. Ann Surg Oncol 8: 215-221.
73. Huang Q, Ye J, Huang Q, Chen W, Wang L, et al. (2010) Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma. Clin Chem Lab Med 48: 263-269.
74. Yang YX, Sun XF, Cheng AL, Zhang GY, Yi H, et al. (2009) Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line. J Cancer Res Clin Oncol 135: 181-189.